2 More Stocks to Profit From the Natural Gas Spike

Encana and Nuvista are taking steps in the right direction and beginning to see the fruits of their labour.

| More on:
The Motley Fool

To follow up on yesterday’s article, “Natural Gas Continues to Spike Higher — How Can You Profit?”, I would like to go further and look at two other energy stocks that I have owned for a while now and that have been performing really well lately, Encana (TSX:ECA)(NYSE:ECA) and Nuvista Energy (TSX:NVA).

Up on big volumes

Encana’s stock price has increased 10% year-to-date on higher than normal volumes. Are institutional investors finally getting back into the stock? The biggest volume in a long time was seen yesterday, with over 8 million shares trading and the stock increasing 1.6%, reaching a high of $21.22 in the day.

Nuvista’s stock price has increased 19.3% year-to-date also on higher-than-normal volumes.

The average price deck that analysts have been using for natural gas has been increasing in recent months as we come to the realization that these estimates for natural gas prices have been too low. This will lead to EPS estimates also rising and natural gas producers showing results that are better than expected.

Improving company fundamentals

The story for both stocks goes beyond natural gas prices; there are also company-specific improvements that both companies are implementing. Some characteristics that these companies share are:

  • Healthy balance sheets
  • Operational improvements: Encana expects a 10% increase in netbacks in 2014 due to cost reduction and capital efficiencies.
  • Strong production increases: Nuvista expects year over year production per share growth in 2014 is expected to be 15%.
  • Good resource base

Foolish bottom line

Renewed interest in these two names is, in my view, based on not only strength in natural gas prices but also the acknowledgement that both companies are taking steps in the right direction and beginning to see the fruits of their labour.

Encana is reporting fourth-quarter and year-end results on February 13, and Nuvista is expected to report in the beginning of March. Based on what I am seeing at this time, I believe that these results will surprise the market to the upside.


This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Karen Thomas owns shares in Encana and Nuvista.

More on Investing

Stock analysts were once excited about construction company Aecon as an investment.

Bull or Bear: Why Analysts Changed Their Tune on Aecon Stock

Analysts had been champing at the bit for the construction company, but the tides have turned.

Read more »

Specialty Brands faces higher raw materials costs.
Dividend Stocks

What’s Next for Premium Brands Stock?

Shares of the specialty food production and distribution company have fallen about 25% since last October.

Read more »

Double exposure of a businessman and stairs - Business Success Concept
Dividend Stocks

2 Interesting Buys in Any Market

Here are two intriguing buys in any market climate that offer defensive appeal as well as growth and income earning…

Read more »

Bank sign on traditional europe building facade
Bank Stocks

Should You Buy Bank Stocks Now?

Canadian bank stocks are getting cheap. Is this the right time to buy?

Read more »

stock data
Stocks for Beginners

2 Reliable Stocks Beginners Can Buy Amid the Market Selloff

As the broader market turmoil continues, new investors can buy these two reliable dividend stocks to get good returns on…

Read more »

Biotech stocks can be good yet risky investments.

Is Bellus Health Stock Still a Buy After 30% Earnings Jump?

The biotech continues to make progress on obtaining FDA approval for its chronic-cough therapy.

Read more »

Dividend Stocks

TFSA Investors: 3 TSX Stocks for Tax-Free Passive Income

These Canadian corporations have strong visibility over future earnings and dividend payouts.

Read more »

Piggy bank next to a financial report

Do You Have Cash Sitting in Your TFSA? Now Is a Great Time to Buy Stocks

If you have cash in your TFSA that you're looking to invest, now is a great time to buy high-quality…

Read more »